Huntsman CEO Details $400M+ Synergy Plan, $500M 2027 EBITDA Target in Olin Merger Update
HUN sits 35% above its 52-week low of $7.295.
Summary
Huntsman's Q2 2026 earnings call revealed a detailed synergy roadmap for the Olin merger: $300M in cost savings plus $100M+ from chlorine contract replacement, with a 2027 EBITDA target of ~$500M. The CEO stressed that investor rewards will come only after execution.
Key Events · M&A and Partnerships · HUN
-
Synergy Breakdown Revealed
CEO detailed $300M in cost synergies: $75M from purchasing/logistics, $75M from epoxy overlap and integration, $150M from SG&A. An additional $100M+ will come from replacing a chlorine supply contract after its 2030 expiration.
-
2027 EBITDA Target Set at ~$500M
CFO projected ~$500M in 2027 EBITDA for the combined company, based on moderate improvements in construction, housing, aerospace, and power markets.
-
Investor Skepticism Acknowledged
CEO noted investors are in 'show me' mode, wanting proof of synergy realization before rewarding the stock. He emphasized that the synergy numbers are bottom-up, not consultant-driven.
-
Chlorine Contract Delays Full Benefits
The largest chlorine supply contract runs through end of 2030, meaning the $100M+ synergy from internal supply will not be fully realized until after that date.
Analysis · HUN · Industrial Applications And Services
On today's Q2 2026 earnings call, Huntsman's CEO provided the most detailed synergy breakdown yet for the Olin merger: $300M in cost synergies (purchasing, epoxy overlap, SG&A) plus an additional $100M+ from replacing a chlorine contract after 2030. The CFO projected ~$500M in 2027 EBITDA, assuming moderate economic recovery. The CEO acknowledged investor skepticism, framing the deal as a 'show me' story where execution will determine the stock's re-rating. This level of granularity on synergy sources and timing, combined with a concrete EBITDA target, gives investors a clearer framework to value the combined entity — but also highlights that full benefits are years away, with the largest chlorine contract not expiring until end of 2030.
At the time of this filing, HUN was trading at $9.84 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $1.7B. The 52-week trading range was $7.30 to $16.09. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.